Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon

No need for a refrigerator with these vaccines

Vaccinations are the first step in providing life-saving healthcare for a variety of deadly diseases. While vaccines are common place in many countries, people residing in developing counties have little access due to the complications involved in transporting and preserving these medications. The development of a new vaccine that doesn’t need refrigeration could be the answers people need.

Thumbnail

House vote on ACA replacement postponed

House Republican leaders have chosen to call off a planned vote on the American Health Care Act (AHCA), their replacement for the Affordable Care Act (ACA), as last-minute revisions and negotiations failed to guarantee enough support to pass the bill.

Thumbnail

Cleveland Clinic operating income drops by 71%

Revenues were up at the Cleveland Clinic in 2016, but higher expenses put a damper on operating income, which fell 71 percent from the year before.

3D printer produces implantable cartilage

Researchers from two Swedish universities have successfully used 3D printing to produce human cartilage cells capable of living and growing in mice. This development, published in Plastic and Reconstructive Surgery Global Open, may be able to provide patients with body parts through 3D printing.

500,000 healthcare jobs added because of ACA

A new analysis from Goldman Sachs said that 500,000 of the jobs added to the healthcare sector since 2012 can be attributed to the Affordable Care Act (ACA)’s increasing of health insurance coverage. 

Thumbnail

Possible repeal of required health benefits draws ire of public hospitals, ER docs

In last-minute negotiations on the American Health Care Act (AHCA), eliminating the 10 “essential health benefits” requirements put in place by the Affordable Care Act (ACA) was floated as an option to win over conservative lawmakers, a development which was quickly opposed by groups representing public hospitals and emergency physicians.

Trump HHS budget proposal raises FDA user fees

President Donald Trump's 2018 budget proposal for the U.S. Department of Health and Human Services (HHS) includes a doubling of U.S. Food and Drug Administration (FDA) user fees, putting added strain on small digital health businesses.

Thumbnail

Major players remain opposed to ACA replacement ahead of House vote

The American Medical Association (AMA), the American College of Physicians (ACP) and the American Academy of Family Physicians (AAFP) have all come out against passage of the American Health Care Act (AHCA), the Republican-sponsored plan to replace the Affordable Care Act (ACA), which is scheduled for a vote before the full House of Representatives on March 23.

Displaying 4833 - 4840 of 6646

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup